HomeSearchPrintBookmarkEmailHelp

Matt Kirmayer
Member of the Firm

Palo Alto
Tel: 650.433.5702 | Fax: 650.433.5703


Download VCard    PDF Version
Matt is a Member of the Firm at Lowenstein Sandler and a member of its Tech Group in the firm’s Palo Alto office. Matt enjoys the excitement of working with new technologies and the entrepreneurs that develop and bring those technologies to market, and focuses his practice on the representation of emerging technology companies, venture capital and private equity funds, and institutional investors. He represents clients in many industries, including digital media, clean technology and renewable energy, Internet infrastructure and security, nanotechnology, life sciences, and medical devices. When working with emerging growth companies, Matt often serves the role of general counsel, advising on formation, assisting with introductions to, and negotiations with, angel and venture capital investors and, when it all works to plan, an IPO or sale transaction.

Matt has practiced corporate law for more than two decades, and has worked on hundreds of financings, IPOs and M&A transactions. In addition to enjoying the breadth and depth of the entrepreneurial and financing world in Silicon Valley, Matts take advantage of his roots in NY City and the firm’s leadership position there, and maintain an active practice counseling companies in the Northeast, particularly those seeking access to venture capital on the West Coast.

Matt is proud to be actively involved in a number of organizations, including Astia, an international nonprofit organization that supports and promotes women as entrepreneurs and leaders of high-growth businesses, and represent the firm by serving on Astia’s Advisory Board. He also serves as a mentor and guest speaker at the Lester Center for Entrepreneurship and Innovation at the Haas School of Business at the University of California, Berkeley, and has sponsored and participated in the annual business plan competition at the Haas School of Business for many years.

His practice is also international: Matt works closely with New Zealand Trade & Enterprise - the New Zealand government’s economic development agency, Auckland UniServices Limited, the largest research and development company of its kind in Australasia and a wholly-owned company of The University of Auckland, and the leading New Zealand venture capital funds to assist New Zealand-based emerging growth companies in their US financing activities and expansion.

Prior to joining the firm, Matt was a partner in the Palo Alto office of Mintz Levin. He began his career in New York City, handling securities offerings and merger and acquisition transactions.

Matt earned an LL.M from New York University School of Law, a J.D., from Rutgers University School of Law, and a B.A., from the State University of New York at Albany.

Recent Transactions

  • $50M Series G Preferred Stock financing for a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery.
  • Series A Preferred Stock financing for a company that has developed unique digital in-mold decoration technologies for injection molded plastics.
  • Series B Preferred Stock financing for a company that has developed and is actively licensing its transbuccal drug delivery technology for safe and rapid delivery of pharmaceutical agents.
  • $1M Seed financing for a company that has developed tools to help mobile application developers spread their applications using the viral nature of the social web.
  • Representation of a private equity investor in a $24M investment in a company that provides online continuing education and training for licensed and certified professionals in the engineering, architectural, construction and post-acute healthcare industries.
  • Representation of a New Zealand emerging growth company in its migration to the US and $4.5M venture financing. The company has pioneered technology solutions that enable the capture and transmission of comprehensive physiological data on the wearer via mobile and fixed data networks, enabling genuine remote monitoring of human performance and condition in the real world.





  • In a Slate's BizBox article, Matt Kirmayer comments on the Obama administration's turn toward embracing business and deregulation and the effect it could have on the venture capital industry., Slate's BizBox, February 25, 2011

  • Lowenstein Sandler's addition of Matt Kirmayer as Member of the Firm in its Palo Alto office is highlighted., Biz Journal, Silicon Valley/San Jose Business Journal, Dow Jones Factiva, Private Equity Analyst, The Deal, November 11, 2010

    wonderfully talented team exercises brilliant judgment and undertakes the most thorough research to ensure nothing slips through the cracks
    – Chambers USA Guide




    Corporate
    The Tech Group
    Venture Capital, Angel Investing, and M&A


    Education

    New York University School of Law (LL.M., 1985)
    Rutgers University School of Law - Newark (1984)
    State University of New York at Albany (1981)




    New York
    California


    © 2012 Lowenstein Sandler PC. In California, Lowenstein Sandler LLP.   Attorney Advertising